Friends don’t let friends be on 4 bottles of glaucoma eyedrops! Check out this exciting news story where Steven R. Sarkisian, Jr., MD and his patient share their experience with iDose TR (travoprost intracameral implant) 75 mcg. Please see here For Important Safety Information https://bit.ly/iDoseISI. KFOR Oklahoma's News 4
Glaukos Corporation
Medical Equipment Manufacturing
Aliso Viejo, CA 24,459 followers
Pioneering new treatments for chronic eye diseases
About us
At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
- Website
-
http://www.glaukos.com/
External link for Glaukos Corporation
- Industry
- Medical Equipment Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Aliso Viejo, CA
- Type
- Public Company
- Founded
- 1998
- Specialties
- Glaucoma, MIGS, Medical Device, Keratoconus, Corneal Crosslinking, Ophthalmic, Corneal Health, Retina, Medical Device, and Pharmaceuticals
Locations
-
Primary
Get directions
26600 Aliso Viejo Parkway
Aliso Viejo, CA 92656, US
-
Get directions
229 Avenida Fabricante
San Clemente, CA 92653, US
-
Get directions
30 North Avenue
Burlington, MA 01803, US
Employees at Glaukos Corporation
Updates
-
Debbie Ristvedt, DO is one of the first doctors participating in the iDose Your Dose program, heading on a journey to support patients in Sierra Leone, West Africa. Because of this program, for every iDose® TR sold, Glaukos pledges to make available an equal number of iDose TR units for qualifying charitable donation requests around the globe. Learn more about the iDose Your Dose program here ➡️ https://lnkd.in/e-S7QEEd
-
It's #NationalFoodTruckDay! Once a month we bring in a food truck! It's our way to say thank you to our employees for all that they do, while supporting local small businesses. Hungry for a career change? See our job openings at https://bit.ly/3XLn6z7
-
-
Glaukos has a rich history of milestones and achievements, but what really matters are the untold successes that are yet to come.
Glaukos Day
-
Could it be KC? Simply by following the keratoconus clues that are hiding in plain sight, you can help patients preserve their vision by referring them to a corneal specialist. Check out KC File #1: "The Patient Who Corrects to 20/20," featuring detective work from Mitch “Private Eye” Ibach OD, FAAO. It’s time to #FollowTheClues.➡️ https://lnkd.in/gaTaCKQ4 Ulcerative keratitis can occur. Patients should be monitored for resolution of epithelial defects. Visit https://bit.ly/ISI_KC for Important Safety Information.
-
It’s official, our summer interns are here! Spread across our 3 campuses, we are excited to introduce them to the world of ophthalmology and allow them the opportunity to learn and grow. #summerinterns #candysalad #makeitsweet
-
Glaukos is committed to investing in the future of ophthalmology to transform the standard of care and improve patient lives. Our dedication to continuous innovation has resulted in an unrivaled pipeline of novel therapies. #Glaukos
We'll go first.
-
iDetectives can spot the clues and promptly refer patients with suspected progressive keratoconus to a corneal specialist who can confirm whether treatment with iLink® is appropriate. 94% of iLink® corneal cross-linking cases have been shown to slow or halt the progression of keratoconus. Make a referral you can trust—your patients will thank you for it! It’s time to #FollowTheClues.➡️ https://lnkd.in/gaTaCKQ4 Ulcerative keratitis can occur. Patients should be monitored for resolution of epithelial defects. Visit https://bit.ly/ISI_KC for Important Safety Information.